Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics is a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI). Their mission is to enhance the quality and speed of recovery for patients suffering from traumatic injuries or undergoing reconstructive surgeries, utilizing innovative technologies such as NTX-001, a nerve fusion system, and specialized microsurgical instruments.
Industries
Nr. of Employees
small (1-50)
Neuraptive Therapeutics, Inc.
851 Duportail Road, Suite 200, Chesterbrook, PA 19087
Neuraptive Therapeutics, Inc. is currently seeking investment
Neuraptive Therapeutics, Inc. is seeking a late-stage investment in the range of 20m-50m
Patents
Device and method of creating a fluid containment field for administering therapeutics to a nerve
2023-04-25 • US-11633188-B2
View Details
Device and method of creating a fluid containment field for administering therapeutics to a nerve
2023-04-25 • US-11633188-B2
View DetailsProducts
Surgical nerve repair kit (fusion reagents + topical delivery device + microsurgical instruments)
A sterile, single-use surgical kit intended for use with standard neurorrhaphy that combines a membrane-fusion reagent protocol, a topical delivery device for nerves, and nerve-specific microsurgical instruments to restore electrical continuity across severed peripheral nerves and reduce axonal degeneration.
Surgical nerve repair kit (fusion reagents + topical delivery device + microsurgical instruments)
A sterile, single-use surgical kit intended for use with standard neurorrhaphy that combines a membrane-fusion reagent protocol, a topical delivery device for nerves, and nerve-specific microsurgical instruments to restore electrical continuity across severed peripheral nerves and reduce axonal degeneration.
Expertise Areas
- Clinical trial management
- Peripheral nerve therapeutics
- Surgical device and kit development
- Topical drug delivery for surgery
Key Technologies
- PEG-mediated membrane fusion
- Topical nerve drug-delivery devices
- Nerve-specific microsurgical instruments
- Single-use sterile surgical kits
Key People
News & Updates
Neuraptive Therapeutics announces FDA clearance of IND application for NTX-001, a novel approach for treating peripheral nerve injuries.
Plans to initiate a Phase 2 clinical study for NTX-001 in the prevention of postoperative facial paralysis.
Neuraptive Therapeutics announces FDA clearance of IND application for NTX-001, a novel approach for treating peripheral nerve injuries.
Plans to initiate a Phase 2 clinical study for NTX-001 in the prevention of postoperative facial paralysis.